KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Receivables - Other: 2023-2024

Historic Receivables - Other for Exact Sciences (EXAS) over the last 2 years, with Dec 2024 value amounting to $25.9 million.

  • Exact Sciences' Receivables - Other fell 34.16% to $31.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.8 million, marking a year-over-year decrease of 34.16%. This contributed to the annual value of $25.9 million for FY2024, which is 37.89% down from last year.
  • Per Exact Sciences' latest filing, its Receivables - Other stood at $25.9 million for FY2024, which was down 37.89% from $41.7 million recorded in FY2023.
  • Exact Sciences' Receivables - Other's 5-year high stood at $41.7 million during FY2023, with a 5-year trough of $25.9 million in FY2024.
  • For the 2-year period, Exact Sciences' Receivables - Other averaged around $33.8 million, with its median value being $33.8 million (2023).
  • Data for Exact Sciences' Receivables - Other shows a maximum YoY slumped of 37.89% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Exact Sciences' Receivables - Other stood at $41.7 million in 2023, then plummeted by 37.89% to $25.9 million in 2024.